Proteasome impairment does not contribute to pathogenesis in R6/2 Huntington's disease mice: exclusion of proteasome activator REGgamma as a therapeutic target

scientific article published on 25 November 2005

Proteasome impairment does not contribute to pathogenesis in R6/2 Huntington's disease mice: exclusion of proteasome activator REGgamma as a therapeutic target is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/HMG/DDI423
P698PubMed publication ID16311253
P5875ResearchGate publication ID7458226

P50authorGillian BatesQ5562196
P2093author name stringGregory Pratt
Martin Rechsteiner
Ben Woodman
John S Bett
Geoffrey M Goellner
P433issue1
P921main subjectHuntington's diseaseQ190564
P304page(s)33-44
P577publication date2005-11-25
P1433published inHuman Molecular GeneticsQ2720965
P1476titleProteasome impairment does not contribute to pathogenesis in R6/2 Huntington's disease mice: exclusion of proteasome activator REGgamma as a therapeutic target
P478volume15